A Hosmann1, A Schober2, A Gruber1, F Sterz2, C Testori2, A Warenits2, W Weihs2, S Högler3, T Scherer4, A Janata2, A Laggner2, Markus Zeitlinger5. 1. Department of Neurosurgery, Medical University of Vienna, Vienna, Austria. 2. Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria. 3. University of Veterinary Medicine, Vienna, Austria. 4. Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. 5. Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.
Abstract
BACKGROUND: In clinical practice, monitoring of the efficacy of resuscitation can be challenging. The prediction of cerebral and overall outcome in particular is an unmet medical need. Microdialysis is a minimally invasive technique for the continuous determination of metabolic parameters in vivo. Using this technique, we set out to establish a model allowing for concomitant determination of cerebral and peripheral metabolism in a cardiac arrest setting in rodents. METHODS: Microdialysis settings were optimized in vitro and then used in male Sprague-Dawley rats. Probes were implanted into the CA1 region of the right hippocampus and the right femoral vein. With a time interval of 8 min, glucose, lactate, pyruvate, and glutamate levels were determined during baseline conditions, untreated ventricular fibrillation cardiac arrest, cardiopulmonary resuscitation (CPR), reperfusion, and death. RESULTS: In 16 rodents, restoration of spontaneous circulation was achieved in seven animals. Characteristic metabolic changes were evident during cardiac arrest and reperfusion with both probes. Ischemic patterns in peripheral compartments were delayed and more variable compared to the changes in cerebral metabolism highlighting the importance of cerebral metabolic monitoring. Microdialysis allowed distinguishing between survivors and non-survivors 8 min after termination of CPR. Cerebral glutamate showed a trend toward higher levels in non-survivors during CPR. CONCLUSIONS: We established a new rodent model for research in hypoxic ischemic encephalopathy. This setting allows to investigate the impact of resuscitation methods on cerebral and peripheral metabolism simultaneously. The present model may be used to evaluate different resuscitation strategies in order to optimize brain survival in future studies.
BACKGROUND: In clinical practice, monitoring of the efficacy of resuscitation can be challenging. The prediction of cerebral and overall outcome in particular is an unmet medical need. Microdialysis is a minimally invasive technique for the continuous determination of metabolic parameters in vivo. Using this technique, we set out to establish a model allowing for concomitant determination of cerebral and peripheral metabolism in a cardiac arrest setting in rodents. METHODS: Microdialysis settings were optimized in vitro and then used in male Sprague-Dawley rats. Probes were implanted into the CA1 region of the right hippocampus and the right femoral vein. With a time interval of 8 min, glucose, lactate, pyruvate, and glutamate levels were determined during baseline conditions, untreated ventricular fibrillation cardiac arrest, cardiopulmonary resuscitation (CPR), reperfusion, and death. RESULTS: In 16 rodents, restoration of spontaneous circulation was achieved in seven animals. Characteristic metabolic changes were evident during cardiac arrest and reperfusion with both probes. Ischemic patterns in peripheral compartments were delayed and more variable compared to the changes in cerebral metabolism highlighting the importance of cerebral metabolic monitoring. Microdialysis allowed distinguishing between survivors and non-survivors 8 min after termination of CPR. Cerebral glutamate showed a trend toward higher levels in non-survivors during CPR. CONCLUSIONS: We established a new rodent model for research in hypoxic ischemicencephalopathy. This setting allows to investigate the impact of resuscitation methods on cerebral and peripheral metabolism simultaneously. The present model may be used to evaluate different resuscitation strategies in order to optimize brain survival in future studies.
Authors: Marx Runge; Pia Hughes; Jens Peter Gøtze; Rene H Petersen; Daniel A Steinbrüchel Journal: Scand Cardiovasc J Date: 2006-06 Impact factor: 1.589
Authors: Paul Vespa; Marvin Bergsneider; Nayoa Hattori; Hsiao-Ming Wu; Sung-Cheng Huang; Neil A Martin; Thomas C Glenn; David L McArthur; David A Hovda Journal: J Cereb Blood Flow Metab Date: 2005-06 Impact factor: 6.200
Authors: L Pellerin; G Pellegri; P G Bittar; Y Charnay; C Bouras; J L Martin; N Stella; P J Magistretti Journal: Dev Neurosci Date: 1998 Impact factor: 2.984
Authors: Asita Sarrafzadeh; Daniel Haux; Ingeborg Küchler; Wolfgang R Lanksch; Andreas W Unterberg Journal: J Neurosurg Date: 2004-03 Impact factor: 5.115
Authors: Alessandro Putzu; Silvia Valtorta; Giuseppe Di Grigoli; Matthias Haenggi; Sara Belloli; Antonio Malgaroli; Marco Gemma; Giovanni Landoni; Luigi Beretta; Rosa Maria Moresco Journal: Neurocrit Care Date: 2018-06 Impact factor: 3.210
Authors: Cesar Reis; Onat Akyol; Camila Araujo; Lei Huang; Budbazar Enkhjargal; Jay Malaguit; Vadim Gospodarev; John H Zhang Journal: Int J Mol Sci Date: 2017-01-11 Impact factor: 5.923
Authors: Ingrid Anna Maria Magnet; Florian Ettl; Andreas Schober; Alexandra-Maria Warenits; Daniel Grassmann; Michael Wagner; Christoph Schriefl; Christian Clodi; Ursula Teubenbacher; Sandra Högler; Wolfgang Weihs; Fritz Sterz; Andreas Janata Journal: Shock Date: 2017-12 Impact factor: 3.454
Authors: Peggy L Nguyen; Laith Alreshaid; Roy A Poblete; Geoffrey Konye; Jonathan Marehbian; Gene Sung Journal: Front Neurol Date: 2018-09-11 Impact factor: 4.003